Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells VD Dixit, EM Schaffer, RS Pyle, GD Collins, SK Sakthivel, R Palaniappan, ... The Journal of clinical investigation 114 (1), 57-66, 2004 | 1219 | 2004 |
Collagen–chitosan polymeric scaffolds for the in vitro culture of human epidermoid carcinoma cells N Shanmugasundaram, P Ravichandran, PN Reddy, N Ramamurty, S Pal, ... Biomaterials 22 (14), 1943-1951, 2001 | 436 | 2001 |
Preparation, characterization, cytotoxicity and transfection efficiency of poly (DL-lactide-co-glycolide) and poly (DL-lactic acid) cationic nanoparticles for controlled … A Basarkar, D Devineni, R Palaniappan, J Singh International Journal of Pharmaceutics 343 (1-2), 247-254, 2007 | 129 | 2007 |
Azo polymeric hydrogels for colon targeted drug delivery KL Shantha, P Ravichandran, KP Rao Biomaterials 16 (17), 1313-1318, 1995 | 127 | 1995 |
Preparation, swelling characteristics and evaluation of hydrogels for stomach specific drug delivery P Ravichandran, KL Shantha, KP Rao International journal of pharmaceutics 154 (1), 89-94, 1997 | 78 | 1997 |
Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage R Palaniappan, S Singh, UP Singh, SKK Sakthivel, EW Ades, DE Briles, ... Infection and immunity 73 (2), 1006-1013, 2005 | 63 | 2005 |
CCL5 modulates pneumococcal immunity and carriage R Palaniappan, S Singh, UP Singh, R Singh, EW Ades, DE Briles, ... The Journal of Immunology 176 (4), 2346-2356, 2006 | 54 | 2006 |
Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate D Ezekwudo, R Shashidharamurthy, D Devineni, E Bozeman, ... Cancer letters 270 (2), 277-285, 2008 | 46 | 2008 |
Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer D Patel, AE Knowell, M Korang-Yeboah, P Sharma, J Joshi, S Glymph, ... Molecular endocrinology 28 (8), 1239-1253, 2014 | 28 | 2014 |
Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization M Korang-Yeboah, Y Gorantla, SA Paulos, P Sharma, J Chaudhary, ... International journal of nanomedicine, 4763-4781, 2015 | 26 | 2015 |
PACE-A microspheres for delivery of antigens J Lillard, R Palaniappan, P Koritala US Patent App. 10/340,848, 2004 | 25 | 2004 |
Inactivation of ID 4 promotes a CRPC phenotype with constitutive AR activation through FKBP 52 JB Joshi, D Patel, DJ Morton, P Sharma, J Zou, D Hewa Bostanthirige, ... Molecular oncology 11 (4), 337-357, 2017 | 16 | 2017 |
Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: effect of size determining formulation process variables of … D Devineni, D Ezekwudo, R Palaniappan Journal of microencapsulation 24 (4), 358-370, 2007 | 15 | 2007 |
Viral macrophage-inflammatory protein-II: a viral chemokine that differentially affects adaptive mucosal immunity compared with its mammalian counterparts UP Singh, S Singh, P Ravichandran, DD Taub, JW Lillard The Journal of Immunology 173 (9), 5509-5516, 2004 | 14 | 2004 |
Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth M Korang-Yeboah, D Patel, D Morton, P Sharma, Y Gorantla, J Joshi, ... Oncotarget 7 (42), 68072, 2016 | 12 | 2016 |
Gellan-gum nanoparticles and methods of making and using the same R Palaniappan US Patent 8,389,012, 2013 | 8 | 2013 |
Approaches and issues towards development of efficient mucosal vaccines against pneumonia D Devineni, S Paulos, R Ubale, B Rayaprolu, R Palaniappan Clinical Research and Regulatory Affairs 26 (3), 39-49, 2009 | 5 | 2009 |
Cancer vaccine development: Designing tumor cells for greater immunogenicity EN Bozeman, R Shashidharamurthy, SA Paulos, R Palaniappan, ... Frontiers in bioscience (Landmark edition) 15, 309, 2010 | 1 | 2010 |
Abstract# 1571: Development and characterization of gellangum-b-peg nanoparticles for prostate cancer therapy B Rayaprolu, D Ezekwudo, S Paulos, S Periasamy, R Palaniappan Cancer Research 69 (9_Supplement), 1571-1571, 2009 | | 2009 |
Blockade of interferon-gamma inducible protein-10 protects mice from cyclophosphamide-induced cystitis SKK Sakthivel, UP Singh, S Singh, R Palaniappan, DD Taub, JW Lillard FASEB JOURNAL 18 (5), A1135-A1135, 2004 | | 2004 |